Answer
Jan 22, 2026 - 01:03 PM
The active ingredient is Bimekizumab-bkzx, which is a humanized IgG1 monoclonal antibody. IgG1 stands for Immunoglobulin G1, a type of antibody engineered to target specific proteins involved in inflammation. This targeted action is valuable because it helps treat the underlying cause of plaque psoriasis more precisely, potentially leading to better outcomes.
